Effects of a leucine™ and pyridoxine-containing nutraceutical on body weight and composition in obese subjects

References

• Sun X Zemel M Leucine and calcium regulate fat metabolism and energy partitioning in murine adipocytes and muscle cells Lipids 2007 42 297 305 17406924
   PubMed Web of Science ®Google Scholar
• Sun X Zemel MB Leucine modulation of mitochondrial mass and oxygen consumption in skeletal muscle cells and adipocytes Nutr Metab (Lond) 2009 6 26 19500359
   PubMed Web of Science ®Google Scholar
• Macotela Y Emanuelli B Bang AM Dietary leucine – an envrionmental modifier of insulin resistance acting on multiple levels of metabolism PLoS One 2011 6 e21187 21731668
   PubMed Web of Science ®Google Scholar
• Donato JJr Pedrosa RG Cruzat VF Pires IS Tirapegui J Effects of leucine supplementation on the body composition and protein status of rats submitted to food restriction Nutrition 2006 22 520 527 16600817
   PubMed Web of Science ®Google Scholar
• Zhang Y Guo K LeBlanc RE Loh D Schwartz GJ Yu YH Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms Diabetes 2007 56 1647 1654 17360978
   PubMed Web of Science ®Google Scholar
• Bruckbauer A Zemel MB Effects of dairy consumption on SIRT1 and mitochondrial biogenesis in adipocytes and muscle cells Nutr Metab (Lond) 2011 8 91 22185590
   PubMed Web of Science ®Google Scholar
• Bruckbauer A Zemel MB Thorpe T Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice Nutr Metab (Lond) 2012 9 77 22913271
   PubMed Web of Science ®Google Scholar
• Zemel MB Bruckbauer A Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects Nutrients 2012 4 529 541 22822451
   PubMed Web of Science ®Google Scholar
• Xue B Zemel M Relationship between human adipose tissue agouti and fatty acid synthase (FAS) J Nutr 2000 130 2478 2481 11015476
   PubMed Web of Science ®Google Scholar
• Kim J Kiefer L Woychik R Agouti regulation of intracellular calcium: role of melanocortin receptors Am J Physiol 1997 272 E379 E384 9124542
   PubMed Web of Science ®Google Scholar
• Xue B Greenberg A Kraemer F Zemel M Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes FASEB J 2001 15 2527 2529 11641262
   PubMed Web of Science ®Google Scholar
• Xue B The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism FASEB J 1998 12 1391 1396 9761782
   PubMed Web of Science ®Google Scholar
• Shi H Moustaid-Moussa N Wilkison W Zemel M Role of the sulfonylurea receptor in regulating human adipocyte metabolism FASEB J 1999 13 1833 1838 10506587
   PubMed Web of Science ®Google Scholar
• Rossmeislova L Malisova L Kracmerova J Weight loss improves adipogenic capacity of human preadipocytes and modulates their secretory profile Diabetes 2013 62 1990 1995 23378611
   PubMed Web of Science ®Google Scholar
• Olszanecka-Glinianowicz M Chudek J Szromek A Zahorska-Markiewicz B Changes of systemic microinflammation after weight loss and regain – a five-year follow up study Endokrynol Pol 2012 63 432 438 23339000
   PubMed Web of Science ®Google Scholar
• Phelan S Wadden TA Berkowitz RI Impact of weight loss on the metabolic syndrome Int J Obes (Lond) 2007 31 1442 1448 17356528
   PubMed Web of Science ®Google Scholar
• Colon-Gonzalez F Kim GW Lin JE Valentino MA Waldman SA Obesity pharmacotherapy: what is next? Mol Aspects Med 2013 34 71 83 23103610
   PubMed Web of Science ®Google Scholar
• Capurso C Capurso A From excess adiposity to insulin resistance: the role of free fatty acids Vascul Pharmacol 2012 57 91 97 22609131
   PubMed Web of Science ®Google Scholar
• Boden G Obesity and free fatty acids Endocrinol Metab Clin North Am 2008 37 635 646 viii–ix 18775356
   PubMed Web of Science ®Google Scholar
• Medina-Gomez G Mitochondria and endocrine function of adipose tissue Best Pract Res Clin Endocrinol Metab 2012 26 791 804 23168280
   PubMed Web of Science ®Google Scholar
• Fujihara S Mori H Kobara H Metabolic syndrome, obesity, and gastrointestinal cancer Gastroenterol Res Pract 2012 2012 483623 23304125
   PubMed Web of Science ®Google Scholar
• Srivastava RA Pinkosky SL Filippov S Hanselman JC Cramer CT Newton RS AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases J Lipid Res 2012 53 2490 2514 22798688
   PubMed Web of Science ®Google Scholar
• Scarpulla RC Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network Biochim Biophys Acta 2011 1813 1269 1278 20933024
   PubMed Web of Science ®Google Scholar
• Canto C Gerhart-Hines Z Feige JN AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 2009 458 1056 1060 19262508
   PubMed Web of Science ®Google Scholar
• Xu XJ Pories WJ Dohm LG Ruderman NB What distinguishes adipose tissue of severely obese humans who are insulin sensitive and resistant? Curr Opin Lipidol 2013 24 49 56 23298959
   PubMed Web of Science ®Google Scholar
• Gauthier MS O’Brien EL Bigornia S Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans Biochem Biophys Res Commun 2011 404 382 387 21130749
   PubMed Web of Science ®Google Scholar
• Bergeron R Previs SF Cline GW Perret P Russell RR3rd Young LH Shulman GI Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats Diabetes 2001 50 1076 1082 11334411
   PubMed Web of Science ®Google Scholar
• Pold R Jensen LS Jessen N Long-term AICAR administration and exercise prevents diabetes in ZDF rats Diabetes 2005 54 928 934 15793229
   PubMed Web of Science ®Google Scholar
• Cool B Zinker B Chiou W Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome Cell Metab 2006 3 403 416 16753576
   PubMed Web of Science ®Google Scholar
• Lagouge M Argmann C Gerhart-Hines Z Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 2006 127 1109 1122 17112576
   PubMed Web of Science ®Google Scholar
• Feige JN Lagouge M Canto C Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metab 2008 8 347 358 19046567
   PubMed Web of Science ®Google Scholar
• Lopez-Otin C Blasco MA Partridge L Serrano M Kroemer G The hallmarks of aging Cell 2013 153 1194 1217 23746838
   PubMed Web of Science ®Google Scholar
• Schriever SC Deutsch MJ Adamski J Roscher AA Ensenauer R Cellular signaling of amino acids towards mTORC1 activation in impaired human leucine catabolism J Nutr Biochem 2013 24 824 831 22898570
   PubMed Web of Science ®Google Scholar
• Stancliffe RA Eades M Smart K Zemel MB Role of mTOR and β-hydroxy-β-methylbutyrate (HMB) in leucine stimulation of muscle mitochondrial biogenesis and fatty acid oxidation FASEB J 2011 25 601.1
   Web of Science ®Google Scholar
• Stancliffe RA Zemel MB Role of β-hydroxy-β-methylbutyrate (HMB) in leucine stimulation of muscle mitochondrial biogenesis FASEB J 2012 26 251.6
   Web of Science ®Google Scholar